Xcout Intel
Ensho Therapeutics, Inc.
Ensho Therapeutics, Inc. is a privately held, clinical-stage biopharmaceutical company focused on developing breakthrough oral therapies for patients. Founded in 2024, the company is based in Morris Plains, New Jersey.
Subscribe to see Ensho Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Ensho Therapeutics, Inc. at a glance
Ensho Therapeutics, Inc. is a drug discovery company headquartered in United States. Its most recent funding round raised $20M in January 2026. Xcout tracks 19 named people at Ensho Therapeutics, Inc., including Gerhard Hagn (Chief Executive Officer).
Ensho Therapeutics, Inc. leadership
- Gerhard HagnChief Executive Officer
- Neena Bitritto-GargPresident and CEO
- Danielle FryChief Operating Officer and Chief Legal Officer
- Andy WhitneyChief Scientific Officer
- Tory TrippeVice President, Head of Finance and Corporate Development
- Bittoo KanwarExecutive Officer
13 more named people on record for Ensho Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
Ensho Therapeutics, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $20M | — | |
| SEC Form D filing | $22.5M | — | |
| Debt | $5M | — | |
| SEC Form D filing | $400,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ensho Therapeutics, Inc. competitors
A few of Ensho Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
KayoThera, Inc. is an early-stage, preclinical therapeutics company headquartered in Seattle, Washington. The firm focuses on developing first-in-class, oral, small molecule treatments.
Promontory Therapeutics Inc. is a privately held, clinical-stage pharmaceutical company founded in 2010 and headquartered in New York, NY. The firm focuses on small molecule immunotherapy.
Bridge Medicines LLC is a drug discovery holding company headquartered in New York, NY, that accelerates the path of therapeutic pipelines from research to patients.
Momotaro-Gene Inc. is a drug discovery company established in 2007 and headquartered in Okayama, Japan. The company focuses on pharmaceutical research and the development of next-generation cancer therapeutics.
Aneira Pharma, Inc. is a privately held pharmaceutical company founded in 2008 with its headquarters in San Diego, California.
Engrail Therapeutics, Inc. is a clinical-stage neurosciences and pharmaceutical company established in 2019 and headquartered in San Diego, California. The firm focuses on developing novel treatments such as its planned ENX-104 clinical program.
Get Ensho Therapeutics, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Ensho Therapeutics, Inc. in Xcout Intel
- 19 named people with titles, LinkedIn and board committees
- 4 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access